Y
Yun Ling
Researcher at Fudan University
Publications - 92
Citations - 7161
Yun Ling is an academic researcher from Fudan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 62 publications receiving 5190 citations. Previous affiliations of Yun Ling include University of Paris & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia.
Fengxiang Song,Nannan Shi,Fei Shan,Zhiyong Zhang,Jie Shen,Hongzhou Lu,Yun Ling,Yebin Jiang,Yuxin Shi +8 more
TL;DR: Patients with fever and/or cough and with conspicuous ground-glass opacity lesions in the peripheral and posterior lungs on CT images, combined with normal or decreased white blood cells and a history of epidemic exposure, are highly suspected of having 2019 Novel Coronavirus (2019-nCoV) pneumonia.
Journal ArticleDOI
Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
Yun Ling,Shui Bao Xu,Yi Xiao Lin,Di Tian,Zhao Qin Zhu,Fa Hui Dai,Fan Wu,Zhi gang Song,Wei Huang,Jun Chen,Bijie Hu,Sheng Wang,En Qiang Mao,Lei Zhu,Wen Hong Zhang,Hong Zhou Lu +15 more
TL;DR: The clearance time and factors influencing 2019 novel coronavirus (2019-nCoV) RNA in different samples from patients with COVID-19 were analyzed, providing further evidence to improve the management of patients during convalescence and showed that the CD4+ T lymphocyte count may help predict the duration of viral RNA detection in patients’ stools.
Journal ArticleDOI
Viral and host factors related to the clinical outcome of COVID-19.
Xiaonan Zhang,Yun Tan,Yun Ling,Gang Lu,Feng Liu,Zhigang Yi,Xiaofang Jia,Min Wu,Bisheng Shi,Shuibao Xu,Jun Chen,Wei Wang,Bing Chen,Lu Jiang,Shuting Yu,Jing Lu,Jinzeng Wang,Mingzhu Xu,Zhenghong Yuan,Qin Zhang,Xinxin Zhang,Guoping Zhao,Shengyue Wang,Sai-Juan Chen,Hongzhou Lu +24 more
TL;DR: Clinical data from 326 cases suggest that T cell depletion and cytokine bursts are associated with a worse prognosis, and genomic sequences from 112 patients with confirmed SARS-CoV-2 virus showed two clades with similar virulence and clinical outcome.
Journal ArticleDOI
COVID-19 with Different Severities: A Multicenter Study of Clinical Features.
Yun Feng,Yun Ling,Tao Bai,Yusang Xie,Jie Huang,Jian Li,Weining Xiong,Dexiang Yang,Rong Chen,Fang-Ying Lu,Yunfei Lu,Xuhui Liu,Yuqing Chen,Xin Li,Yong Li,Hanssa Dwarka Summah,Huihuang Lin,Jiayang Yan,Min Zhou,Hongzhou Lu,Jieming Qu +20 more
TL;DR: Multiple organ dysfunction and impaired immune function were the typical characteristics of patients with severe or critical illness and there was a significant difference in the use of angiotensin-converting enzyme inhibitors/angiotens in II receptor blockers among patients with different severities of disease.
Journal ArticleDOI
Clinical progression of patients with COVID-19 in Shanghai, China.
Jun Chen,Tangkai Qi,Li Liu,Yun Ling,Zhiping Qian,Tao Li,Feng Li,Qingnian Xu,Yuyi Zhang,Shuibao Xu,Zhigang Song,Yigang Zeng,Yinzhong Shen,Yuxin Shi,Tongyu Zhu,Hongzhou Lu +15 more
TL;DR: The clinical progression pattern suggests that early control of viral replication and application of host-directed therapy in later stage is essential to improve the prognosis of CVOID-19.